TMThermo Fisher Scientific statistics
$700.22+0.11%Close 13 Nov 2026
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
| Enterprise value | $294.9B |
|---|
| EV / EBITDA | 25.48 |
|---|
| EV / sales | 6.23 |
|---|
Share price
| Latest close | $700.22 |
|---|
| Day's change | +0.1% |
|---|
| 52-week high | $727.56 |
|---|
| 52-week low | $435.27 |
|---|
| From 52-week high | −3.8% |
|---|
| Return · 1 month | +1.5% |
|---|
| Return · 3 months | +11.6% |
|---|
| Return · year to date | +20.8% |
|---|
| Return · 1 year | +19.1% |
|---|
| Beta · 1 year against the S&P 500 | 0.69 |
|---|
| 50-day average | $670.62 |
|---|
| 200-day average | $555.37 |
|---|
| RSI 14 | 53.7 |
|---|
| Average volume · 20 sessions | 2.2M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 40.9% |
|---|
| Operating margin | 17.4% |
|---|
| Net margin | 15.0% |
|---|
| Free cash flow margin | 14.1% |
|---|
| Return on equity | 13.0% |
|---|
| Return on assets | 6.9% |
|---|
| Return on invested capital | 8.2% |
|---|
| Return on capital employed | 8.6% |
|---|
| Stock-based compensation / revenue | 0.7% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $9.85B |
|---|
| Total debt | $40.85B |
|---|
| Net debt | $30.75B |
|---|
| Current ratio | 1.89 |
|---|
| Debt / equity | 0.76 |
|---|
| Net debt / EBITDA | 2.92 |
|---|
| Interest coverage | 5.46 |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 378M |
|---|
| Net share repurchases | $3.00B |
|---|
| Dividends per share | $1.72 |
|---|
| Dividend payout | 9.5% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $547.0M |
|---|
| Effective tax rate | 7.5% |
|---|
TMO in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.